Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study.

by Sun Min Lim, Dong Phil Choi, Yumie Rhee, Hyeon Chang Kim
Published 2015-01-01

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

by Jiyun Lee, Zofia Piotrowska, Ross Soo, Byoung Chul Cho, Sun Min Lim
Published 2022-12-01

Advances in the management of non-small-cell lung cancer harbouring exon 20 insertion mutations

by Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo
Published 2023-01-01

Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response

by Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon
Published 2024-05-01

Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-...

by Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Published 2024-03-01

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma

by Ahreum Kim, Ahreum Kim, Sun Min Lim, Joo-Hang Kim, Joo-Hang Kim, Jeong-Sun Seo, Jeong-Sun Seo
Published 2021-02-01

Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report

by Sangho Nam, MD, Sun Min Lim, MD, PhD, Byoung Chul Cho, MD, PhD, Jii Bum Lee, MD
Published 2024-02-01

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

by Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim
Published 2022-03-01

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.

by Yoon Jin Cha, Jae Seok Lee, Hye Ryun Kim, Sun Min Lim, Byoung Chul Cho, Chang Young Lee, Hyo Sup Shim
Published 2014-01-01

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study

by Beung-Chul Ahn, Jee Hung Kim, Kyoung-Ho Pyo, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Published 2021-07-01

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

by Ji Hyun Lee, Seong Gu Heo, Beung‐Chul Ahn, Min Hee Hong, Byoung Chul Cho, Sun Min Lim, Hye Ryun Kim
Published 2021-10-01

Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme.

by Sun Min Lim, Junjeong Choi, Jong Hee Chang, Jinyoung Sohn, Kristine Jacobson, Frank Policht, John Schulz, Byoung Chul Cho, Se Hoon Kim
Published 2015-01-01

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

by Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Suyog Jain, Steve Olsen, Byoung Chul Cho
Published 2023-01-01

Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer

by Min Jung Geum, Chungsoo Kim, Ji Eun Kang, Jae Hee Choi, Jae Song Kim, Eun Sun Son, Sun Min Lim, Sandy Jeong Rhie
Published 2021-05-01

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution.

by Hyung Soon Park, Sun Min Lim, Sora Kim, Sangwoo Kim, Hye Ryun Kim, KyuBum Kwack, Min Goo Lee, Joo-Hang Kim, Yong Wha Moon
Published 2016-01-01

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice

by Byoung Chul Cho, Herbert H. F. Loong, Chun-Ming Tsai, Man Lung P. Teo, Hye Ryun Kim, Sun Min Lim, Suyog Jain, Steve Olsen, Keunchil Park
Published 2022-03-01

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib

by Sun Min Lim, MD, PhD, San-Duk Yang, PhD, Sangbin Lim, PhD, Hyo Sup Shim, MD, PhD, Byoung Chul Cho, MD, PhD
Published 2021-06-01

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treat...

by Beung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, Kyoung-Ho Pyo, Choong-kun Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Published 2021-06-01

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

by Sun Min Lim, San-Duk Yang, Sangbin Lim, Seong Gu Heo, Stetson Daniel, Aleksandra Markovets, Rafati Minoo, Kyoung-Ho Pyo, Mi Ran Yun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Published 2022-02-01

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

by Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Published 2024-12-01